Immediate Impact

35 standout
Sub-graph 1 of 17

Citing Papers

ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
2 intermediate papers

Works of Mehran Kouchek being referenced

A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19
2021
Comparison of Intravenous Ampicillin-sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial.
2019

Author Peers

Author Last Decade Papers Cites
Mehran Kouchek 27 38 56 48 47 34 268
Seyedpouzhia Shojaei 53 29 45 27 39 31 306
Zahra Sahraei 34 22 47 28 29 27 308
Fabiano Márcio Nagel 58 16 74 35 79 19 316
Muhammet Şükrü Paksu 21 43 88 19 34 32 320
Dipu T Sathyapalan 31 33 68 25 59 40 290
Sukrit Kanchanasurakit 7 14 67 37 51 24 295
Reza Mosaed 14 20 25 31 56 19 227
Carmen D’Amore 27 11 62 16 14 32 277
Mairi Ziaka 41 51 62 59 30 35 295
Naci Murat 18 32 37 16 11 39 306

All Works

Loading papers...

Rankless by CCL
2026